IRIS
SVEGLIATI BARONI, SILVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.162
EU - Europa 2.381
AS - Asia 1.747
SA - Sud America 590
AF - Africa 87
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 5
AN - Antartide 1
Totale 8.981
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.096
SG - Singapore 581
BR - Brasile 501
UA - Ucraina 427
CN - Cina 376
IT - Italia 313
SE - Svezia 292
DE - Germania 285
RU - Federazione Russa 253
IE - Irlanda 238
VN - Vietnam 211
TR - Turchia 208
HK - Hong Kong 176
DK - Danimarca 155
FI - Finlandia 113
FR - Francia 96
GB - Regno Unito 92
KR - Corea 86
CA - Canada 39
AR - Argentina 32
CI - Costa d'Avorio 32
PL - Polonia 27
IN - India 24
MA - Marocco 22
ID - Indonesia 19
AT - Austria 18
BE - Belgio 18
MX - Messico 18
EC - Ecuador 17
ZA - Sudafrica 16
BD - Bangladesh 15
NL - Olanda 14
CO - Colombia 13
ES - Italia 11
JP - Giappone 10
PY - Paraguay 10
LT - Lituania 9
EU - Europa 6
IQ - Iraq 6
TN - Tunisia 6
VE - Venezuela 6
AU - Australia 5
EG - Egitto 5
PK - Pakistan 5
RS - Serbia 5
SA - Arabia Saudita 5
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
EE - Estonia 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
HN - Honduras 2
NI - Nicaragua 2
PE - Perù 2
RO - Romania 2
SR - Suriname 2
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
MD - Moldavia 1
MW - Malawi 1
NA - Namibia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.981
Salva come PNG Salva come JPEG
Città #
Chandler 604
Jacksonville 434
Ashburn 406
Singapore 360
Boardman 239
Dublin 235
Dallas 190
Fairfield 183
Hong Kong 176
New York 145
Beijing 138
Wilmington 137
Lawrence 93
Princeton 93
Centro 87
San Mateo 87
Woodbridge 86
Ho Chi Minh City 82
Des Moines 81
Ann Arbor 79
Houston 76
Los Angeles 76
The Dalles 70
Munich 61
Seattle 58
São Paulo 58
Hefei 55
Moscow 54
Cambridge 49
Buffalo 43
Hanoi 43
San Diego 33
Turin 32
Abidjan 31
Ancona 31
London 24
Warsaw 24
Turku 21
Nuremberg 19
Rio de Janeiro 18
Brussels 16
Montreal 16
Chicago 15
San Francisco 15
Guangzhou 14
Helsinki 14
Stockholm 14
Denver 12
Santa Clara 12
Washington 12
Izmir 11
Marche 11
Shanghai 11
Atlanta 10
Belo Horizonte 10
Da Nang 10
Orem 10
Poplar 10
Boston 9
Johannesburg 9
Pune 9
Wuhan 9
Chennai 8
Mexico City 8
Milan 8
Monte San Pietrangeli 8
Phoenix 8
Porto Alegre 8
Redmond 8
Tokyo 8
Ankara 7
Juneau 7
Toronto 7
Amsterdam 6
Biên Hòa 6
Brasília 6
Brooklyn 6
Bắc Ninh 6
Columbus 6
Council Bluffs 6
Curitiba 6
Goiânia 6
Guarulhos 6
Guayaquil 6
Haiphong 6
Itaquaquecetuba 6
Jesi 6
Jinhua 6
Ottawa 6
Vienna 6
Belgrade 5
Bologna 5
Caxias do Sul 5
Falls Church 5
Hải Dương 5
Manchester 5
Quận Một 5
Quận Phú Nhuận 5
Salvador 5
São Bernardo do Campo 5
Totale 5.307
Salva come PNG Salva come JPEG
Nome #
Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti−Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies 165
Metabolomic profile of systemic sclerosis patients 151
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 143
Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach 140
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease–associated spondyloarthritis 138
c-MYB transactivates the alpha 2(I) collagen gene. 137
A reactive Oxygen species -mediated loop mantains increased expression of NADPH oxidases 2 and 4 in skin fibroblasts from patients with systemic sclerosis 135
Agonistic anti-PDGF receptor autoantibodies from patients with systemic sclerosis impact human pulmonary artery smooth muscle cells function in vitro 135
Epitope specificity determines pathogenicity and detectability of anti-platelet-derived growth factor receptor α autoantibodies in systemic sclerosis 134
ALTERATIONS OF ROS PATHWAYS IN SCLERODERMA BEGIN AT STEM CELL LEVEL 133
B CELL RECEPTOR EDITING IN SCLERODERMA PATIENTS GENERATES PATHOGENIC ANTI-PDGFR AUTOANTIBODIES 130
Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice 126
Activation in vitro of scleroderma skin fibroblasts is sustained by increased generation of free radicals through the NADPH-oxidase pathway. 124
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 124
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 122
Long lasting biological effects of PDGFR agonistic auto-antibodies in scleroderma 121
Bone formation by distraction clinical and structural studies 121
Sclerostin and Antisclerostin Antibody Serum Levels Predict the Presence of Axial Spondyloarthritis in Patients with Inflammatory Bowel Disease 120
DETECTION OF STIMULATORY ANTI-PDGF RECEPTOR AUTOANTIBODIES BY BIOASSAYS BASED ON DIFFERENT CELL LINES 117
Platelet-derived growth factor and reactive oxygen species (ROS) regulate Ras protein levels in primary human fibroblasts via ERK 1/2. Amplification of ROS and Ras in systemic sclerosis fibroblasts 115
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis 110
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 109
Characterization of the c-Myb-responsive region and regulation of the human type I collagen α2 chain gene by c-Myb 109
Ha-Ras/ERK1-2 pathway is responsable for oxygen species generation by scleroderma skin fibroblasts 108
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 108
Agonistic antibodies in systemic sclerosis 107
Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality 106
Cloning of agonistic autoantibodies specific for the PDGF receptor from the B-cell repertoire of SSc patients 104
AUTOIMMUNITY TO PDGFR: A RELEVANT PATHOGENIC LINK IN SSc 102
The long pentraxin PTX3 is a marker of scleroderma fibroblasts activation 101
The Wnt signalling inhibitor gene, WIF1, is silenced in fibroblasts derived from Systemic Sclerosis patients: role of oxidative stress 100
Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: Role of NADPH oxidase and ERK1/2 99
WIF1, A WNT PATHWAY INHIBITOR, IS SILENCED IN SYSTEMIC SCLEROSIS BY DNA DAMAGE: A MECHANISM LINKING DNA DAMAGE TO WNT AND FIBROSIS 98
Mechanism of action of agonistic PDGFR auto-antibodies isolated from scleroderma patients 98
Stimulatory autoantibodies against PDGF receptors in Scleroderma 97
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 97
Pathogenic autoantibodies in systemic sclerosis 96
Autoantibodies against the platelet-derived growth factor receptor in scleroderma: comment on the articles by Classen et al and Loizos et al. 96
CLONING OF AGONISTIC AUTOANTIBODIES SPECIFIC FOR THE PDGF RECEPTOR FROM THE B CELL REPERTOIRE OF PATIENTSAFFECTED BY SYSTEMIC SCLEROSIS 96
NADPH oxidase, oxidative stress and fibrosis in systemic sclerosis 94
Reduced type I collagen gene expression by skin fibroblasts of patients with systemic sclerosis after one treatment course with rituximab 93
Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis 93
Stimulating autoantibodies to PDGF A/B receptor on sera from scleroderma patients 92
Coenzyme Q homologs and vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the ageing rat. 91
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 91
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes 91
Putative functional pathogenic autoantibodies in systemic sclerosis 91
Solid monounsaturated diet lowers LDL unsaturation trait and oxidisability in hypercholesterolemic (type IIb) patients 90
Ha-Ras/ERK1-2 pathway is responsible for oxygen species generation in scleroderma fibroblasts 90
Stimulatory autoantibodies against PDGF receptor in systemic sclerosis 89
Oxidative DNA damage induces the ATM-mediated transcriptional suppressionof the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis 88
Dietary restriction affects antioxidant levels in rat liver mitochondria during ageing 87
Scleroderma fibroblasts constitutively express the long pentraxin PTX3. 87
PDGF receptor as therapeutic and diagnostic target in systemic sclerosis 86
Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvemen 86
Tissue-targeted antifibrotic gene therapy using a transgene driven by the promoter of the human type I collagen gene 85
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets 85
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 84
Oxidative stress and the pathogenesis of scleroderma: the Murrell's hypothesis revisited. 84
Coenzyme Q homologs and Vitamin E in synaptic and non-synaptic occipital cerebral cortex mitochondria in the aging rat 84
Dietary restriction affects antioxidant levels in rat liver mitochondria diuring aging 83
Biological effects of serum immunoglobulins from scleroderma patients on human pulmonary artery smooth muscle cells. Role of NOX4 and ROS 83
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches 83
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 82
PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis 82
Stimulatory Auto-Antibodies To The PDGF Receptor As Pathology Marker And Therapeutic Target 81
Association between TNF-α, cortisol levels, and exposure to PM10 and PM2.5: a pilot study 80
The treatment of UCD200 and scleroderma fibroblasts with siRNAs anti-C-MYB blocks type I collagen transcription: Toward a gene therapy of scleroderma 80
Treatment With Rituximab Reduces Activation Of Scleroderma Dermal Fibroblasts 80
Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents 80
The Wnt signalling inhibitor gene, WIF-1, expression is downregulated in fibroblasts derived from systemic sclerosis patients by a persistent oxidative stress 79
H-Ras but not K-Ras is responsible for reactive oxygen species generation by scleroderma skin fibroblasts. 78
Oxidative stress in scleroderma - Maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway 77
Development of a Skin-Humanized Model as a Novel Tool to Investigate the Pathogenesis of Scleroderma 77
Stimulatory auto-antibodies to the PDGF receptor in patients with chronic GVHD. 76
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 76
Isolation and cloning of stimulatory anti-PDGF receptor auto-antibodies from the immunological repertoire of patients with systemic sclerosis 75
Lipid raft colocalization of PDGFR-NADPH complex and receptor integrity are important for the activation of the intracellular signaling by scleroderma IgG in normal human fibroblasts 75
Rituximab for the treatment of cutaneous involvement in systemic sclerosis. evidence for a pathogenetic role of B-CELLS 72
Unbalance between Ha- and Ki-Ras is responsible for scleroderma fibroblast activation 70
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis 69
The important role of molecular analyses to evaluate the efficacy of Rituximab treatment in a patient affected by severe multineuropathy in mixed cryoglobulinemia disease. 69
Isolation of agonistic autoantibodies specific for the PDGF receptor from the B cell repertoire of SSC patients 69
Stimulatory autoantibodies to the PDGF receptor in scleroderma (Correspondence) 68
Reactive oxygen species are required for manteinance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. 68
Stimulatory autoantibodies against PDGF receptor in serum from patients with GVHD and scleroderma-like changes. 67
Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof 65
Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of free radical generation through the NADPH oxidase complex pathway 64
STIMULATORY AUTOANTIBODIES AGAINST PDGF RECEPTOR IN A LARGE COHORT OF ITALIAN SCLERODERMA PATIENTS 64
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 64
Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q10 and vitamin E contents 62
Restricted immunoglobulin repertoire and evolutionary mechanism of PDGFR-autoreactive memory B cells in systemic sclerosis 58
Intracellular free radical production by peripheral blood T lymphocytes from patients with Systemic Sclerosis: role of NADPH oxidase and ras 56
New insights into the role of oxidative stress in scleroderma fibrosis. 55
Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study 54
Dietary olive oil affects LDL peroxidability in hypercholesterolemic (IIB) patients 50
Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine 49
Expression profile and regulation of NOX proteins in Systemic Sclerosis 46
Totale 9.099
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.900
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021555 0 0 0 0 0 55 99 44 129 67 120 41
2021/2022614 36 169 9 32 11 24 14 56 42 32 51 138
2022/20231.530 134 188 110 161 138 202 6 98 366 9 82 36
2023/2024752 140 29 40 125 127 170 9 12 0 15 6 79
2024/20251.553 149 145 68 12 93 18 174 43 353 103 168 227
2025/20262.203 379 491 235 502 467 129 0 0 0 0 0 0
Totale 9.099